Champions Oncology Inc Stock
Price
Target price
€5.10
€5.10
2.410%
0.12
2.410%
-
24.04.26 / Frankfurt
WKN: A14X6S / Name: Champions / Stock / Biotechnology & Medical Research / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Champions Oncology Inc Stock
There is an upward development for Champions Oncology Inc compared to yesterday, with an increase of €0.12 (2.410%).
Pros and Cons of Champions Oncology Inc in the next few years
Pros
?
M***** P*******
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
Cons
?
B****
?
S********** s********
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Champions Oncology Inc vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Champions Oncology Inc | 2.410% | 0.990% | 4.082% | -20.930% | -12.069% | 10.870% | -42.697% |
| Sangamo Therapeutics Inc. | -29.780% | -28.034% | -47.326% | -77.235% | -53.545% | -89.092% | -98.322% |
| Evolus Inc | -0.620% | 13.182% | 16.719% | -56.059% | -17.761% | -42.168% | -41.792% |
| Corbus Pharmaceuticals Holding Inc. | -2.290% | 1.805% | 20.552% | 34.462% | 24.857% | 6696.267% | -79.570% |
News
U.S. Polo Assn. Supports Division I National Intercollegiate Championship, Showcasing the Future of the Sport of Polo
DI Women's and Men's Finals to be Featured in ‘Breakaway: Polo in College' on ESPN
WEST PALM BEACH, FLA. / ACCESS Newswire / April 2, 2026 / U.S. Polo Assn., the official sports brand of
Champions Oncology Names Brian Alexander to Board as Company Advances Data-Driven Oncology Strategy
Appointment underscores Champions' focus on leveraging clinically relevant data to power next-generation oncology R&D
HACKENSACK, NJ / ACCESS Newswire / March 30, 2026 / Champions Oncology,
3 Dividend Champions to Buy and Hold for Decades
There's a saying on Wall Street that "dividends don't lie." Just about every financial metric can be spun by a company's management, but dividends either arrive in the mail or they don't. Companies
